THE EFFECT OF LOGOTHERAPY ON DEPRESSION IN CANCER PATIENTS: A SYSTEMATIC REVIEW STUDY

被引:0
作者
Koulaee, A. Jafari [1 ]
Khenarinezhad, F. [1 ]
Abutalebi, M. [2 ]
Bagheri-Nesami, M. [3 ]
机构
[1] Mazandaran Univ Med Sci, Student Res Comm, Nursing, Sari, Iran
[2] Mazandaran Univ Med Sci, Student Res Comm, Psychiat Nursing, Sari, Iran
[3] Mazandaran Univ Med Sci, Addict Inst, Tradit & Complementary Med Res Ctr, Sari, Iran
关键词
Logotherapy; Depression; Cancer; Review;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the effect of logotherapy factors on the severity of depression in cancer patients. Materials and Methods: The present review study was conducted in 2017. In order to find evidence in this regard, the English-language and Persian-language scientific bases (PubMed, Elsevier, Science direct, SID, Google scholar, ProQuest) were searched for determined keywords such as Logotherapy (Depression or Depressive disorders) and (Cancer or Tumor or Neoplasm or Malignancy). Out of the 79 articles found after removing duplicate and non-related ones, finally, 6 articles were selected for the study process based on the inclusion criteria. Results: Based on the results, in two studies from six obtained studies, intervention was done on patients with breast cancer and in another study was conducted on subjects with colorectal cancer under chemotherapy. The minimum and maximum number of logotherapy sessions was 8 and 10 sessions, respectively. The meetings also lasted from 45 minutes to 120 minutes. After intervention, depression significantly decreased in cancer patients. Conclusions: Logotherapy can play a significant role in lowering depression in patients with cancer. It is suggested that in order to have more effective sessions, the duration and number of logotherapy sessions could be determined according to the severity of depression and patient's condition.
引用
收藏
页数:6
相关论文
共 38 条
  • [1] Abolghasami S.H., 2010, WOMAN CULTURE, V2, P31
  • [2] Bener Abdulbari, 2017, Asian Pac J Cancer Prev, V18, P1889
  • [3] Bhattacharyya Sutanay, 2017, Indian J Public Health, V61, P14, DOI 10.4103/0019-557X.200252
  • [4] Bolhari J, 2012, J SOC WOMEN, V3, P85
  • [5] Global cancer transitions according to the Human Development Index (2008-2030): a population-based study
    Bray, Freddie
    Jemal, Ahmedin
    Grey, Nathan
    Ferlay, Jacques
    Forman, David
    [J]. LANCET ONCOLOGY, 2012, 13 (08) : 790 - 801
  • [6] Delavari H, 2014, IRAN J PEDIATR HEMAT, V4, P42
  • [7] Ebrahimi N, 2014, IRAN J CANCER PREV, V7, P9
  • [8] Improving treatment of depression among low-income patients with cancer: the design of the ADAPt-C study
    Ell, Kathleen
    Quon, Brenda
    Quinn, David I.
    Dwight-Johnson, Megan
    Wells, Anjanette
    Lee, Pey-Jiuan
    Xie, Bin
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2007, 29 (03) : 223 - 231
  • [9] ESPING A, 2011, J BORDER ED RES, V9, P59
  • [10] Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
    Griffiths, Roland R.
    Johnson, Matthew W.
    Carducci, Michael A.
    Umbricht, Annie
    Richards, William A.
    Richards, Brian D.
    Cosimano, Mary P.
    Klinedinst, Margaret A.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2016, 30 (12) : 1181 - 1197